PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 128 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,130,000 | -6.5% | 392,321 | -1.3% | 0.00% | 0.0% |
| Q4 2021 | $1,208,000 | -33.1% | 397,483 | +54.4% | 0.00% | 0.0% |
| Q3 2021 | $1,805,000 | +304.7% | 257,426 | +429.9% | 0.00% | – |
| Q2 2021 | $446,000 | +90.6% | 48,581 | +101.7% | 0.00% | – |
| Q1 2021 | $234,000 | +45.3% | 24,088 | +53.9% | 0.00% | – |
| Q4 2020 | $161,000 | -71.4% | 15,656 | -71.9% | 0.00% | – |
| Q3 2020 | $563,000 | +17.8% | 55,782 | +21.7% | 0.00% | – |
| Q2 2020 | $478,000 | -20.3% | 45,821 | -35.6% | 0.00% | -100.0% |
| Q1 2020 | $600,000 | -63.9% | 71,129 | -62.6% | 0.00% | 0.0% |
| Q4 2019 | $1,664,000 | +74.1% | 190,145 | +114.1% | 0.00% | 0.0% |
| Q3 2019 | $956,000 | +53.9% | 88,811 | +81.6% | 0.00% | 0.0% |
| Q2 2019 | $621,000 | -85.3% | 48,895 | -55.2% | 0.00% | -75.0% |
| Q1 2019 | $4,231,000 | +1062.4% | 109,069 | +509.1% | 0.00% | – |
| Q4 2018 | $364,000 | -83.5% | 17,906 | -62.8% | 0.00% | -100.0% |
| Q3 2018 | $2,207,000 | -10.9% | 48,129 | +15.0% | 0.00% | 0.0% |
| Q2 2018 | $2,476,000 | +12.3% | 41,856 | +29.3% | 0.00% | 0.0% |
| Q1 2018 | $2,204,000 | -34.9% | 32,381 | -5.5% | 0.00% | -33.3% |
| Q4 2017 | $3,388,000 | +88.2% | 34,274 | +128.1% | 0.00% | +50.0% |
| Q3 2017 | $1,800,000 | +162.4% | 15,028 | +91.6% | 0.00% | +100.0% |
| Q2 2017 | $686,000 | +166.9% | 7,844 | +13.5% | 0.00% | – |
| Q1 2017 | $257,000 | -73.8% | 6,908 | -52.8% | 0.00% | -100.0% |
| Q3 2016 | $981,000 | +139.3% | 14,626 | +179.4% | 0.00% | 0.0% |
| Q4 2015 | $410,000 | -38.3% | 5,234 | -40.7% | 0.00% | 0.0% |
| Q3 2015 | $665,000 | +29.4% | 8,826 | +100.5% | 0.00% | 0.0% |
| Q2 2015 | $514,000 | -61.5% | 4,402 | -22.1% | 0.00% | -66.7% |
| Q1 2015 | $1,334,000 | +84.5% | 5,651 | +48.0% | 0.00% | +50.0% |
| Q4 2014 | $723,000 | +227.1% | 3,818 | +80.3% | 0.00% | +100.0% |
| Q1 2014 | $221,000 | – | 2,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |